BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1390 related articles for article (PubMed ID: 27365453)

  • 21. When proteostasis goes bad: Protein aggregation in the cell.
    Radwan M; Wood RJ; Sui X; Hatters DM
    IUBMB Life; 2017 Feb; 69(2):49-54. PubMed ID: 28066979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular chaperones in protein folding and proteostasis.
    Hartl FU; Bracher A; Hayer-Hartl M
    Nature; 2011 Jul; 475(7356):324-32. PubMed ID: 21776078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential Influence of Cyclo(His-Pro) on Proteostasis: Impact on Neurodegenerative Diseases.
    Grottelli S; Costanzi E; Peirce MJ; Minelli A; Cellini B; Bellezza I
    Curr Protein Pept Sci; 2018; 19(8):805-812. PubMed ID: 29708066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Folding of newly translated proteins in vivo: the role of molecular chaperones.
    Frydman J
    Annu Rev Biochem; 2001; 70():603-47. PubMed ID: 11395418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein Misfolding Diseases and Therapeutic Approaches.
    Yadav K; Yadav A; Vashistha P; Pandey VP; Dwivedi UN
    Curr Protein Pept Sci; 2019; 20(12):1226-1245. PubMed ID: 31187709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteomic analysis of protein homeostasis and aggregation.
    Laskowska E; Kuczyńska-Wiśnik D; Lipińska B
    J Proteomics; 2019 Apr; 198():98-112. PubMed ID: 30529741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Chaperones in Neurodegenerative Diseases: A Short Review.
    Bobori C; Theocharopoulou G; Vlamos P
    Adv Exp Med Biol; 2017; 987():219-231. PubMed ID: 28971461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein aggregation in cell biology: An aggregomics perspective of health and disease.
    Cox D; Raeburn C; Sui X; Hatters DM
    Semin Cell Dev Biol; 2020 Mar; 99():40-54. PubMed ID: 29753879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential roles of natural products in the targeting of proteinopathic neurodegenerative diseases.
    Dash R; Jahan I; Ali MC; Mitra S; Munni YA; Timalsina B; Hannan MA; Moon IS
    Neurochem Int; 2021 May; 145():105011. PubMed ID: 33711400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein homeostasis as a therapeutic target for diseases of protein conformation.
    Calamini B; Morimoto RI
    Curr Top Med Chem; 2012; 12(22):2623-40. PubMed ID: 23339312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemical Biology Framework to Illuminate Proteostasis.
    Sebastian RM; Shoulders MD
    Annu Rev Biochem; 2020 Jun; 89():529-555. PubMed ID: 32097570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chaperone networks: tipping the balance in protein folding diseases.
    Voisine C; Pedersen JS; Morimoto RI
    Neurobiol Dis; 2010 Oct; 40(1):12-20. PubMed ID: 20472062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular protein homeostasis in neurodegenerative diseases.
    Wilson MR; Satapathy S; Vendruscolo M
    Nat Rev Neurol; 2023 Apr; 19(4):235-245. PubMed ID: 36828943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small-molecule modulation of cellular chaperones to treat protein misfolding disorders.
    Sloan LA; Fillmore MC; Churcher I
    Curr Opin Drug Discov Devel; 2009 Sep; 12(5):666-81. PubMed ID: 19736625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade.
    Chiti F; Dobson CM
    Annu Rev Biochem; 2017 Jun; 86():27-68. PubMed ID: 28498720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional principles and regulation of molecular chaperones.
    Dahiya V; Buchner J
    Adv Protein Chem Struct Biol; 2019; 114():1-60. PubMed ID: 30635079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Model systems of protein-misfolding diseases reveal chaperone modifiers of proteotoxicity.
    Brehme M; Voisine C
    Dis Model Mech; 2016 Aug; 9(8):823-38. PubMed ID: 27491084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanochaperone-Based Strategies to Control Protein Aggregation Linked to Conformational Diseases.
    Caballero AB; Gamez P
    Angew Chem Int Ed Engl; 2021 Jan; 60(1):41-52. PubMed ID: 32706460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting Hsp70 facilitated protein quality control for treatment of polyglutamine diseases.
    Davis AK; Pratt WB; Lieberman AP; Osawa Y
    Cell Mol Life Sci; 2020 Mar; 77(6):977-996. PubMed ID: 31552448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular chaperones and neuronal proteostasis.
    Smith HL; Li W; Cheetham ME
    Semin Cell Dev Biol; 2015 Apr; 40():142-52. PubMed ID: 25770416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 70.